DG7 SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection

KiTEC re-examined this piece of guidance as a part of NICE's guidance review process, which requires a fresh look at the evidence every 3 years.